Page last updated: 2024-09-05

cirsimaritin and gallocatechol

cirsimaritin has been researched along with gallocatechol in 2 studies

Compound Research Comparison

Studies (cirsimaritin)	Trials (cirsimaritin)	Recent Studies (post-2010) (cirsimaritin)	Studies (gallocatechol)	Trials (gallocatechol)	Recent Studies (post-2010) (gallocatechol)
49	0	21	481	12	218
49	0	21	38	0	20

Protein Interaction Comparison

Protein	Taxonomy	gallocatechol (IC50)
Alpha-synuclein	Homo sapiens (human)	8.9
Mitogen-activated protein kinase 10	Homo sapiens (human)	4.415
Beta-secretase 1	Homo sapiens (human)	2.5
Mitogen-activated protein kinase 14	Homo sapiens (human)	4.415
DNA repair protein RAD52 homolog	Homo sapiens (human)	2.98
Enoyl-acyl-carrier protein reductase	Plasmodium falciparum (malaria parasite P. falciparum)	7

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Backlund, A; Bohlin, L; Gottfries, J; Larsson, J	1
Brun, R; Lack, G; Perozzo, R; Rüedi, P; Scapozza, L; Tasdemir, D	1

Other Studies

2 other study(ies) available for cirsimaritin and gallocatechol

Article	Year
Expanding the ChemGPS chemical space with natural products. Journal of natural products, 2005, Volume: 68, Issue:7 Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship	2005
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. Journal of medicinal chemistry, 2006, Jun-01, Volume: 49, Issue:11 Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Alcohol Oxidoreductases; Animals; Antimalarials; Catechin; Cells, Cultured; Chloroquine; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Flavones; Flavonoids; Humans; Hydro-Lyases; Kinetics; Luteolin; Phenols; Plasmodium falciparum; Polyphenols; Structure-Activity Relationship	2006

Article

Year

Expanding the ChemGPS chemical space with natural products.

Journal of natural products, 2005, Volume: 68, Issue:7

Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship

2005

Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.

Journal of medicinal chemistry, 2006, Jun-01, Volume: 49, Issue:11

Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Alcohol Oxidoreductases; Animals; Antimalarials; Catechin; Cells, Cultured; Chloroquine; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Flavones; Flavonoids; Humans; Hydro-Lyases; Kinetics; Luteolin; Phenols; Plasmodium falciparum; Polyphenols; Structure-Activity Relationship

2006